Although more than 100 types of RNA modification have been described thus far, most of them were thought to be rare in mRNAs and in regulatory noncoding RNAs. Recent developments have unveiled that at least some of the modifications are considerably abundant and widely conserved. This Minireview summarizes the molecular machineries and biological functions of methylation (N6-methyladenosine, m 6 A) and uridylation (U-tail).
RNAs undergo chemical modifications that can affect their activity, localization, and stability (Machnicka et al., 2013) , which is conceptually analogous to the modifications of DNA and protein.
Abundant noncoding RNAs such as rRNAs and tRNAs are extensively modified, whereas mRNA modifications are thought to be relatively low in frequency apart from the common terminal modifications, m 7 G cap and poly(A) tail.
The most abundant internal modification on mRNA is N 6 -methyladenosine (m 6 A), discovered in the 1970s. Early studies estimated m 6 A to be present at a level of approximately three to five sites per mRNA (0.1%-0.4% of adenosines) in mammalian cells (Bokar, 2005; Dubin and Taylor, 1975; Perry et al., 1975; Wei et al., 1975) . But the initial interest was dampened by concerns that m 6 A may have come from contamination from rRNAs and snRNAs and also due to the fact that mutation of specific m 6 A sites did not affect mRNA abundance and processing.
Another concern was that, although viral mRNAs are frequently modified, m 6 A was rarely detected in cellular mRNAs examined, which led to the idea that adenosine methylation may occur in a limited subset of viral and cellular mRNAs (Bokar, 2005) . After four decades of latency, however, the interest in m 6 A has been renewed recently by developments of new sequencing techniques and discoveries from genetic and biochemical studies.
Another ''old'' modification that recently regained attention is tailing (3 0 terminal untemplated nucleotidyl addition), which was initially noted in the 1970s (Norbury, 2013) . Apart from canonical polyadenylation, it is now clear that RNAs undergo multiple types of tailing, including noncanonical adenylation, uridylation, and guanylation (Chang et al., 2014; Norbury, 2013) . Tailing plays important roles in the small RNA pathways (Ameres and Zamore, 2013; Ha and Kim, 2014) . Accumulating evidence suggests that mRNAs are also subject to widespread regulatory tailing such as uridylation (Chang et al., 2014; Morozov et al., 2010; Mullen and Marzluff, 2008; Rissland and Norbury, 2009; Sement et al., 2013) . The recent development of a highthroughput method now offers an opportunity to examine the 3 0 terminal modification of mRNA at the transcriptome level (Chang et al., 2014) . This Minireview will focus on two emerging modifications, m 6 A and U-tail, and will summarize recent technical developments, as well as the enzymology and biological significance of methylation and uridylation.
N6-Methyladenosine in mRNA m 6 A modification is found in rRNA, snRNA, and mRNA of viruses, yeast, plants, and animals and is particularly prevalent in higher eukaryotes (Bokar, 2005) . The consensus sequence of m 6 A was initially predicted from several m 6 A-containing mRNA sequences and was defined as ' (Harper et al., 1990) . However, the in vivo methylation state of the predicted m 6 A sites remained largely unknown due to technical limitations. This changed when two groups independently developed similar methods, MeRIPseq (methylated RNA immunoprecipitation followed by sequencing) and m 6 A-seq (Dominissini et al., 2012; Meyer et al., 2012) . To briefly explain the methods, RNA is fragmented into $100 nt long segments and is immunoprecipitated with antim 6 A antibody, which results in selective enrichment of methylated RNA fragments. Eluted RNAs and input control samples are deep sequenced, and the reads are mapped to the genome. Using peak-calling algorithms, regions enriched in the immunoprecipitate relative to input samples are identified as ''m 6 A peaks.'' These methods allowed genome-wide mapping of m 6 A modification with a resolution of $200 nt, detected over 12,000 m 6 A peaks in transcripts of >7,000 genes in human cells and mouse tissues. Many of the m 6 A peaks are conserved between mouse and human, and they are enriched near the stop codon. These studies also revealed that the methylation status of some m 6 A sites dynamically changes in stress conditions, implicating a potential role of m 6 A in stress responses. The genome-wide m 6 A mapping in two yeast species (S. cerevisiae and S. mikatae) also demonstrated a conserved and dynamically regulated methylation during meiosis (Schwartz et al., 2013) . Other various technical approaches have been taken by other groups to detect m 6 A. Methylation of a specific site can be quantitated by a digestion-based method called SCARLET (site-specific cleavage and radioactive-labeling followed by ligation-assisted extraction and thin-layer chromatography), although it cannot be adopted to transcriptomic analyses because it is based on thin-layer chromatography (Liu et al., 2013) . When applied to several individual mRNAs and long ncRNAs, SCARLET assays estimated the percentages of m 6 A at specific sites to range from 6% to 80%. Additional methods such as m 6 A-sensitive ligase reaction and reverse transcription have also been proposed and need to be tested further (Dai et al., 2007; Harcourt et al., 2013; Vilfan et al., 2013) . Additional breakthroughs came from the identification of factors involved in m 6 A regulation. The pathway is composed of three classes of protein factors: ''writers'' (that methylate adenosine at N6 position), ''erasers'' (that demethylate m 6 A for reversible regulation), and ''readers'' (the effectors that control the modified mRNA's fate) ( Figures 1A and 1B) .
The writer of m 6 A is a multicomponent complex composed of METTL3 (also known as MT-A70), METTL14, and WTAP in mammals (Bokar et al., 1997; Liu et al., 2014; Narayan and Rottman, 1988; Ping et al., 2014; Wang et al., 2014b) . Knockdown of METTL3 or METTL14 reduced m 6 A/A ratios in human cell lines and mouse embryonic stem cells (ESCs) (Liu et al., 2014; Ping et al., 2014; Wang et al., 2014b) . Each of METTL3 and METTL14 has methylation activity. But the heterodimer of the two methyltransferases has a strongly enhanced activity in vitro, and they stabilize each other in vivo. METTL3 and METTL14 colocalize in nuclear speckles together with the third component, WTAP. WTAP was initially known as a splicing factor, but its biochemical role remained unknown. Knockdown of WTAP lowered the m 6 A levels and decreased the amount of RNA bound to METTL3, suggesting that WTAP may recruit substrate RNAs to the enzymatic complex (Liu et al., 2014; Ping et al., 2014) . MeRIP-seq and PAR-CLIP (photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation) independently performed in different cell lines revealed that the targets of METTL3 and METTL14 largely overlap (Liu et al., 2014; Wang et al., 2014b) . Moreover, WTAP targets detected by PAR-CLIP also share the binding motif with that of METTL3 and METTL14, which is similar to the m 6 A consensus sequence (Liu et al., 2014; Ping et al., 2014) . These results indicate that the three components function as a heterotrimeric methyltransferase in vivo ( Figure 1B) .
Illustrating their physiological relevance, mutations of the METTL3 or WTAP homologs led to diverse defects in eukaryotes. In S. cerevisiae, the MIS complex containing Ime4 Compared to ALKBH5, FTO has an additional C-terminal domain. YTHDF1,2,3 containing a YTH RNAbinding domain are effector proteins. The P/Q/N-rich domain is known to be important for the localization of YTHDF2 to P body . (C) Proposed model of the cellular function of m 6 A on mRNA. Reversible methylation/demethylation is thought to occur in nuclear speckles where the enzymes are concentrated. Methylation may affect the export and splicing of mRNAs in the nucleus. Exported methylated mRNAs are recognized by YTHDF2 in the cytoplasm and then localize to P bodies, where mRNA decay factors are enriched.
(a METTL3 homolog), Mum2 (a WTAP homolog), and Slz1 is responsible for mRNA methylation during meiosis, and mutations in the MIS components display meiotic defect (Agarwala et al., 2012; Clancy et al., 2002) . In Arabidopsis, disruption of MTA (a METTL3 homolog) causes early developmental arrest and cell division defects (Zhong et al., 2008) . Its depletion at a later stage results in altered growth patterns and floral defects (Bodi et al., 2012) . Drosophila Ime4 (a METTL3 homolog) is critical for viability and is associated with Notch signaling during oogenesis (Hongay and Orr-Weaver, 2011) . In zebrafish, knockdown of METTL3 or WTAP led to multiple defects in early development and increased apoptosis (Ping et al., 2014) . Furthermore, RNAi of Mettl3 or Mettl14 in mouse embryonic stem cells downregulated pluripotency markers and proliferation rates and resulted in morphological changes in ESCs (Wang et al., 2014b) . These studies collectively suggested that RNA methylation is physiologically relevant, though it is yet to be proven that the observed phenotypes are due to methylation of mRNAs rather than that of other RNA classes.
Although the studies of writer made important contributions, a critical breakthrough that revived the m 6 A biology actually came from the discovery of an eraser, fat mass and obesity-associated (FTO). The finding of FTO as an m 6 A demethylase implicated the dynamic and reversible nature of m 6 A modification and established a link to human health. Genome-wide association studies found a strong correlation between a single-nucleotide polymorphism in the first intron of FTO and increased body mass index and obesity risk in multiple human populations. In addition, homozygous loss-of-function mutation (Arg316Gln) is associated with postnatal growth retardation and multiple malformations in humans (Fawcett and Barroso, 2010) . Consistent with the human data, deletion of Fto in mice resulted in altered body weight, increased lethality, and growth retardation (Fawcett and Barroso, 2010) . Fto is most abundantly expressed in the brain, particularly within hypothalamus, which is important for metabolism. Another demethylase, ALKBH5, was recently discovered (Zheng et al., 2013a) . ALKBH5 has the highest expression in testes, and the ALKBH5-deficient mice show defective spermatogenesis and impaired fertility, though the mice are viable and develop to adult normally. The homologs of m 6 A demethylases are yet to be investigated in other species. ALKBH5 appears to be conserved only in vertebrates, whereas FTO homologs have been detected in vertebrates as well as in algae (Zheng et al., 2013b) (Figure 1B ).
FTO and ALKBH5 belong to the AlkB family of the Fe(II) and a-ketoglutarate-dependent dioxygenases. This family also includes demethylases of DNA and histones (Kurowski et al., 2003; Zheng et al., 2013b) . FTO effectively carries out oxidative demethylation of m 6 A on RNA in vitro (Jia et al., 2011) , and ALKBH5 has comparable m 6 A demethylation activity with a preference for the m 6 A consensus sequence (RRACH) (Zheng et al., 2013a) . Silencing or overexpression of these factors resulted in an increase or decrease of m 6 A on mRNA, respectively. FTO forms nuclear foci that partially colocalize with nuclear speckles, whereas ALKBH5 is tightly localized in nuclear speckles that contain splicing factors (Jia et al., 2011; Zheng et al., 2013a) . Knockdown of ALKBH5, but not that of FTO, affects the spliceosome assembly. ALKBH5-depleted cells also show cytoplasmic accumulation of poly(A) + RNA, suggesting that methylation may be necessary for nuclear export of mRNA (Zheng et al., 2013a) . It remains to be determined what the molecular consequences of FTO-mediated demethylation are and how they differ from those of ALKBH5-mediated demethylation.
The m 6 A readers and their effector functions begin to be uncovered. From a pull-down assay using a synthetic m 6 A RNA bait, three YTH domain proteins (YTHDF1-3) have been identified in mammalian cells (Dominissini et al., 2012; Wang et al., 2014a) . The YTH domain family is widespread in eukaryotes and is known to bind to ssRNA through the YTH domain, but their functions were not known (Zhang et al., 2010) . Though all YTHDF1-3 show selective binding to m 6 A embedded in consensus sequences, YTHDF2 has the highest affinity (Wang et al., 2014a) . YTHDF2 target sites identified by PAR-CLIP largely overlap with m 6 A peaks mapped by MeRIP-seq, and they primarily localize near the stop codon. YTHDF2 knockdown led to an increase of abundance and half-lives of target mRNAs, indicating that YTHDF2 is involved in RNA decay. Indeed, mRNA half-lives were increased in accordance with the number of binding sites present in target mRNAs. Via its P/Q/N-rich N-terminal domain, YTHDF2 localizes to processing bodies (P bodies) in the cytoplasm where mRNA turnover factors are concentrated. Thus, YTHDF2 may select m 6 A-modified mRNA through the YTH domain and localize them to the P bodies using N-terminal domain so as to facilitate mRNA decay (Wang et al., 2014a) ( Figures 1B and 1C) .
Apart from mRNA decay (Wang et al., 2014a (Wang et al., , 2014b , several functions of m 6 A have been proposed. Initial studies proposed splicing as the main regulatory target of m 6 A, based on the observations that methylation occurs in the nucleus and that methylation sites are detected in introns of pre-mRNAs (Carroll et al., 1990; Stoltzfus and Dane, 1982) . Global discovery of m 6 A sites showed that some m 6 A sites are indeed located in intronic regions and that alternatively spliced exons and introns are considerably more methylated than constitutively spliced ones (Dominissini et al., 2012) . A similar pattern was observed in PAR-CLIP of METTL3 and WTAP, and depletion of METTL3 or WTAP led to alteration in splicing isoforms (Ping et al., 2014) . In addition to splicing, other RNA processing defects have been reported to be related to methylation. METTL3 knockdown in mouse or human cell lines caused an apparent delay in the nuclear exit of mature mRNA of circadian genes and showed circadian period elongation phenotype (Fustin et al., 2013) . Conversely, depletion of ALKBH5 leads to accelerated mRNA export (Zheng et al., 2013a) (Figure 1C ). It is noteworthy that m 6 A peaks are detected frequently near stop codons. This observation implies a link to translation and/or translationcoupled decay, though these possibilities have yet to be tested directly.
U-Tail in mRNAs and MicroRNAs ''Writers'' of uridylation belong to a large family of ribonucleotidyl transferases that have a catalytic domain with sequence homology to DNA polymerase b (Norbury, 2013) . These proteins were first described as noncanonical poly(A) polymerases (PAPs), based on the findings that ribonucleotidyl transferases such as PAPD4 (GLD2 or TUT2) and mtPAP (TUT1) catalyze adenylation of cytoplasmic mRNA and mitochondrial mRNA, respectively (Tomecki et al., 2004; Wang et al., 2002) . Some ribonucleotidyl transferases have uridylation activity; hence, noncanonical PAPs are also called terminal uridylyl transferases (TUTs) or poly(U) polymerases (PUPs) (Norbury, 2013) . Humans have seven proteins with potential TUT activity. Figure 2A shows five human TUTs that have been proposed to uridylate mRNAs or microRNAs. Although the catalytic domains show sequence homology among TUTs, their overall domain structures have little similarity between species, making it difficult to predict orthologous relationships. Budding yeast S. cerevisiae is the only eukaryotic model organism that lacks an apparent TUT homolog, whereas fission yeast S. pombe possesses at least one TUT.
The first glimpse of uridylation in cytoplasmic RNA came from the description of nontemplated U residues on the 5 0 cleavage products from miRNA-mediated slicing (Shen and Goodman, 2004) . Soon after, miRNA uridylation was found in Arabidopsis HEN1 mutant that is defective in 2 0 -O-methyl modification at the terminal ribose (Li et al., 2005) . Uridylation plays regulatory roles in the miRNA pathway, with the precursor of let-7 (prelet-7) being the most extensively studied example (Heo et al., 2008; Newman et al., 2011 ) ( Figure 2B ). In differentiated cells, precursors of most let-7 members are mono-uridylated by ZCCHC11 (TUT4), ZCCHC6 (TUT7), or PAPD4 (GLD2 or TUT2) (Heo et al., 2012) . Mono-U tail extends the 3 0 overhang of prelet-7 and thereby facilitates Dicer processing and miRNA maturation. But in ESCs and in certain cancer cells in which an oncofetal protein LIN28 or LIN28B is expressed, pre-let-7 is oligo-uridylated, and the long U-tail blocks Dicer processing and inhibits miRNA maturation (Hagan et al., 2009; Heo et al., 2008 Heo et al., , 2009 . Thus, there is a functional duality in uridylation depending on the length of the U-tail. What LIN28 does is to stabilize the interaction between the substrate and TUTs, thereby enhancing processivity of reaction (Yeom et al., 2011) . In animals and plants, there have been many reports of uridylation and adenylation of mature miRNAs, which affect stability and activity of (B) Pre-miRNA uridylation. Microprocessor composed of DROSHA and DGCR8 crops pri-miRNA to release pre-miRNA. Pre-miRNA is exported to the cytoplasm by EXPORTIN5 (EXP5). In embryonic stem cells and in certain cancer cells in which LIN28 or Lin28B is expressed, pre-let-7 is oligo-uridylated by TUT4 or TUT7 and the U-tail blocks Dicer processing and recruits exonuclease DIS3L2. However, in differentiated cells in which LIN28 is absent, precursors of most let-7 members are mono-uridylated by TUT2, TUT4, or TUT7, which facilitates DICER processing. (C) Model for mRNA degradation. Most mRNAs undergo deadenylation at the beginning of decay. Poly(A) tail is removed by deadenylases (shown here as Ccr4-Caf1 complex as an example). Following deadenylation, mRNAs are degraded bidirectionally by Xrn1 following decapping by Dcp1-Dcp2 (5 0 -to-3 0 decay pathway) and by exosome (3 0 -to-5 0 decay pathway). Uridylation is thought to act redundantly with deadenylation in S. pombe to stimulate decapping. TUTase uridylates poly(A) + mRNAs (Cid1 in S. pombe, CutA in A. nidulans, or URT1 in A. thaliana). Lsm1-7 binds to the U-tail and enhances decapping, which triggers 5 0 -to-3 0 decay by Xrn1. (D) Degradation pathway for replication-dependent histone mRNAs. Degradation is initiated by oligo-uridylation. Then LSm1-7 binds to the U-tail and stimulates decapping and 5 0 -to-3 0 decay by XRN1. Some histone mRNAs are also degraded in the 3 0 -to-5 0 direction by 3 0 hExo and PM/Scl-100 (one of exosome components).
miRNAs. Tailing in the small RNA pathway has been reviewed elsewhere in detail (Ameres and Zamore, 2013; Ha and Kim, 2014) .
Mounting evidence indicates that mRNAs are generally subject to uridylation, which challenges the way that we think about mRNA tails ( Figure 2C ). Short uridine tails (typically mono-or di-) were initially found on mRNAs of fission yeast S. pombe (Rissland et al., 2007; Rissland and Norbury, 2009 ). Deletion of the TUTase gene cid1 resulted in an increase of mRNA stability, though it was tested for a single gene (urg1). Uridylated transcripts accumulated when deadenylation factor (Ccr4) or decapping factors (Dcp1 and Lsm1) were mutated. A related phenomenon was observed in filamentous fungus Aspergillus nidulans, where mRNAs frequently contain an extended tail with mixed C and U residues with the consensus CUCU (Morozov et al., 2010 (Morozov et al., , 2012 . When ribonucleotidyl transferase CutA (or CutB) gene was deleted, mRNA decay rate was decreased. These results implicate that uridylation and deadenylation may act redundantly to stimulate decapping and decay of mRNA. Thus, despite differences in sequences, functions of downstream effectors may be conserved among fungi species. Uridylation has also been found on poly(A) + mRNAs of higher eukaryotes, but it remains to be determined whether or not the function of uridylation is conserved. In Arabidopsis, short U-tails occur preferentially on deadenylated mRNAs, suggesting a link to mRNA decay (Sement et al., 2013) . However, in the mutant of urt1, which is responsible for uridylation, 3 0 trimmed decay intermediates accumulated without significant changes in mRNA half-lives. Accordingly, it was proposed that uridylation may simply block 3 0 trimming to establish the 5 0 -to-3 0 directionality of degradation rather than to enhance the rate of decay.
Some poly(A) À RNAs are also known to be uridylated. The replication-dependent histone mRNAs have a conserved stemloop structure instead of a poly(A) tail at their 3 0 end, and they are rapidly degraded at the end of S phase or when DNA replication is inhibited during S phase (Mullen and Marzluff, 2008) . The 3 0 ends of histone mRNAs are oligo-uridylated during their degradation ( Figure 2D ). Recent studies analyzed degradation intermediates of histone mRNA using a circular RT-PCR assay or a high-throughput sequencing approach, revealing that uridylation facilitates decay in both directions (Hoefig et al., 2013; Mullen and Marzluff, 2008; Slevin et al., 2014) . The 5 0 -3 0 degradation is carried out by XRN1 following decapping. The 3 0 -5 0 degradation is mediated initially by 3 0 hExo (also known as Eri1) and subsequently by PM/Scl-100 (a component of exosome; also known as RRP6). When oligo-uridylation is inhibited, the rate of degradation decreased (Mullen and Marzluff, 2008; Schmidt et al., 2011; Su et al., 2013) . As for uridylating enzymes for the histone mRNA, an initial study proposed mtPAP (TUT1) and PAPD5 (TUT3) (Mullen and Marzluff, 2008) , whereas two following reports instead implicated ZCCHC11 (TUT4) (Schmidt et al., 2011; Su et al., 2013) . Other poly(A) À mRNAs such as endonucleolytic cleavage products also seem to be subject to tailing and decay. An example is miRNA-directed 5 0 cleavage products that are oligo-uridylated in plants and mammalian cells, though the TUTs for this reaction are yet to be identified (Shen and Goodman, 2004) . Notably, however, a related phenomenon has been studied in green algae Chlamydomonas (Ibrahim et al., 2006 ). An adenylyl transferase MUT68 mediates oligo-adenylation of the siRNA-mediated cleavage product and induces decay of adenylated RNA.
Further studies are needed to understand the commonalities and variations among these seemingly related phenomena from diverse species. Also, because the above studies were performed on a few individual genes from each species, it is important to examine how widespread uridylation is and how generally it contributes to gene regulation.
Recently, global investigation of mRNA tail was made possible by the development of a high-throughput technique called TAIL-seq (Chang et al., 2014) . Briefly, RNAs are ligated to a biotinylated 3 0 adaptor. Following fragmentation, the 3 0 -most fragments are purified with streptavidin beads and ligated to the 5 0 adaptor. Paired-end sequencing of the cDNA is used to identify the transcript (51 nt from the 5 0 end) and determine the 3 0 tail sequences (231 nt from the 3 0 end). Due to the difficulties associated with sequencing homopolymeric poly(A) tail, fluorescence signals are used for a machine learning algorithm, which allows the accurate determination of poly(A) tail length. TAIL-seq revealed that a surprisingly large proportion of poly(A) + mRNAs are uridylated in mammalian cells (Chang et al., 2014) . More than 85% of mRNA species are uridylated at a frequency of higher than 1%. Most U-tails are short (1-4 uridines) at the steady state. Similarly to plants, U-tails are found mostly on mRNAs with shortened A tails (<$25 nt). Moreover, uridylation frequency correlates negatively with mRNA half-life at the global level. Thus, uridylation may be involved in mRNA decay in most eukaryotes (with some exceptions, such as S. cerevisiae). Because the current model for mRNA decay is largely based on studies of S. cerevisiae that lacks the uridylation machinery, future studies may introduce substantial changes to our understanding of general mRNA decay. It will be important to identify the writer (TUT) for mammalian poly(A) + mRNA and to understand how the uridylyl transferase recognizes nonfunctional mRNAs selectively. It is also necessary to reveal what the direct molecular consequences of uridylation are and if and how uridylation is regulated during developmental and pathological transitions.
It is currently unclear whether uridylation of mRNA and miRNA is a reversible process-that is, whether deuridylase plays a regulatory role as an ''eraser.'' A 3 0 -5 0 exonuclease DIS3L2 has recently been shown to act preferentially on oligo-U-tails of mRNAs (in fission yeast) and on precursor of let-7 (in mice and humans) Malecki et al., 2013; Ustianenko et al., 2013) . The structure of mouse Dis3l2 in complex with an oligo-U (U 14 ) has recently been reported, which showed extensive uracil base-specific interaction (Faehnle et al., 2014) . However, as DIS3L2 degrades the whole RNA body, it would be more appropriate to consider this enzyme as a putative ''reader/ effector.'' It is expected that there are additional effectors that selectively recognize U-tails. For example, the Lsm1-7 complex is known to bind to oligo-U-tracts and enhance decapping in vitro (Song and Kiledjian, 2007) . In yeast, Lsm1-7 complex contributes to the decay of uridylated poly(A) + mRNAs (Rissland and Norbury, 2009) , and in mammals, the Lsm1-7 complex participates in the decay of uridylated histone mRNAs through its interaction with SLBP (stem-loop binding protein) and 3 0 hExo (Hoefig et al., 2013; Lyons et al., 2014; Mullen and Marzluff, 2008) . Thus, the Lsm1-7 complex may be another conserved reader/effector that selectively recognizes U-tails. It is currently unclear what the molecular basis of U-tail recognition is and how many downstream effectors exist.
Perspectives
Pioneering studies on the methylome and 3 0 -terminome of RNA have revealed interesting new layers of gene expression. However, there is yet no consensus as to the exact function of m 6 A and U-tail, and many questions are pending without clear answers. Are there additional writers, erasers, and readers for m 6 A? What are the writers (TUTs) and readers for U-tails of mammalian mRNAs? How do these factors achieve specificity? Is uridylation reversible? How are they regulated and connected to cell-signaling pathways? Which human diseases are associated with such modifications?
Finding the factors involved in the pathway will provide crucial information on the mechanism and function of methylation and uridylation. It is expected that many factors will emerge from affinity purification/immunoprecipitation followed by proteomic analyses. Candidate approaches based on homology to known factors will also be fruitful when combined with RNAi. The following step will be to investigate the factors in detail to gain mechanistic understanding. Structural and biochemical studies of METTL3-METTL14-WTAP and YTHDF2 are much needed to understand how the substrates are selected. Structures of TUT and the higher eukaryotic Lsm1-7 in complex with RNA are also necessary to reveal how U-tail is generated and recognized. Furthermore, genetic studies will teach us what developmental roles the modification factors play, though a caveat is that it would be difficult to segregate their effects on different RNA classes. Genome editing tools are likely to accelerate the functional studies of the modification factors.
There are intriguing commonalities between m 6 A modification and U-tailing. Both modifications are conserved widely in eukaryotes. Both m 6 A and U-tail serve as molecular marks that provide binding sites for their effectors. m 6 A is selectively bound to the YTH domain proteins, whereas U-tail is recognized by DIS3L2 or the Lsm1-7 complex. Intriguingly, the most plausible function of m 6 A and U-tail is to facilitate mRNA decay. It will be interesting to ask whether there is any interplay between these two modifications. The rapid progress in the biology of m 6 A and tailing was possible, in part, due to the development of new technologies that allowed genome-wide detection of the modifications. Although these methods will continue to serve as potent tools, further technical improvement is necessary. For instance, MeRIP-seq and m 6 A-seq suffer from a low resolution, so it is currently impossible to identify the modification sites at a single-nucleotide resolution. In addition, MeRIP-seq and m 6 A-seq can only detect the relative abundance of modification and cannot quantitate the absolute stoichiometry of m 6 A on each site. Additional approaches may become available by combining crosslinking or chemical modification to increase resolution. As for the detection of U-tails, the current method, TAIL-seq, successfully offers genome-wide and quantitative profiles of tail sequences. However, it needs further improvement to effectively remove abundant ncRNA contaminants so as to increase sequencing depth and lower the cost. TAIL-seq is expected to be used not only to investigate uridylation, but also to study other features of 3 0 terminome, such as deadenylation, endonucleolytic cleavage, and guanylation.
In this Minireview, we only dealt with m 6 A and U-tail, but some of the main messages from this area of research are that RNA is not different from DNA or protein in its capacity to be regulated by postsynthetic modifications and that there may be additional underestimated modifications that contribute to gene regulation.
Other types of such ''epitranscriptomic'' modifications may deserve attention in the future, and the potential candidates include pseudouridylation, 5-methyl cytosine, and 2 0 -O-methylation. Effective tools that detect such modifications may open new windows in RNA biology and beyond.
